UK markets open in 6 hours 55 minutes

Prothena Corporation plc (0Y3M.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
55.24+4.58 (+9.03%)
At close: 03:40PM GMT
Full screen
Previous close50.66
Open0.00
Bid0.00 x N/A
Ask0.00 x N/A
Day's range0.00 - 0.00
52-week range
Volume200
Avg. volumeN/A
Market cap18.022M
Beta (5Y monthly)0.50
PE ratio (TTM)0.41
EPS (TTM)1.34
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Prothena (NASDAQ:PRTA) shareholder returns have been strong, earning 299% in 3 years

    The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

  • Business Wire

    Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares

    DUBLIN, December 15, 2022--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it priced an underwritten public offering of 3,250,000 of its ordinary shares at a price to the public of $56.50 per ordinary share, before the underwriting discount and estimated offering expenses. All of the ordinary shares in the offering were sold by Prothena. In add

  • Business Wire

    Prothena Announces Proposed Public Offering of Ordinary Shares

    DUBLIN, December 13, 2022--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it has commenced an underwritten public offering of 3,000,000 of its ordinary shares. All of the ordinary shares in the offering will be sold by Prothena. In addition, Prothena expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the n